Your browser doesn't support javascript.
loading
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
Zhang, Wenjuan; Liang, Yupei; Li, Lihui; Wang, Xiaofang; Yan, Zi; Dong, Changsheng; Zeng, Mu-Sheng; Zhong, Qian; Liu, Xue-Kui; Yu, Jinha; Sun, Shuyang; Liu, Xiaojun; Kang, Jihui; Zhao, Hu; Jeong, Lak Shin; Zhang, Yanmei; Jia, Lijun.
Afiliação
  • Zhang W; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Liang Y; Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Li L; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Wang X; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Yan Z; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Dong C; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zeng MS; Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Zhong Q; Department of Experimental Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Liu XK; Department of Experimental Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Yu J; Department of Head & Neck Cancer, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Sun S; College of Pharmacy, Seoul National University, Seoul, Korea.
  • Liu X; Department of Oral and Maxillofacial-Head Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Kang J; Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhao H; Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Jeong LS; Department of Clinical Laboratory, Huadong Hospital, Shanghai Key Laboratory of Clinical Geriatric Medicine, Research Center on Aging and Medicine, Fudan University, Shanghai, China.
  • Zhang Y; College of Pharmacy, Seoul National University, Seoul, Korea.
  • Jia L; Department of Clinical Laboratory, Huadong Hospital, Shanghai Key Laboratory of Clinical Geriatric Medicine, Research Center on Aging and Medicine, Fudan University, Shanghai, China.
Cell Prolif ; 52(2): e12536, 2019 Mar.
Article em En | MEDLINE | ID: mdl-30341788
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Proteínas Proto-Oncogênicas c-myc / Apoptose / Proteínas Proto-Oncogênicas c-bcl-2 / Ciclopentanos / Inibidores Enzimáticos / Proteína NEDD8 / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço Limite: Humans Idioma: En Revista: Cell Prolif Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Proteínas Proto-Oncogênicas c-myc / Apoptose / Proteínas Proto-Oncogênicas c-bcl-2 / Ciclopentanos / Inibidores Enzimáticos / Proteína NEDD8 / Carcinoma de Células Escamosas de Cabeça e Pescoço / Neoplasias de Cabeça e Pescoço Limite: Humans Idioma: En Revista: Cell Prolif Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido